Predictors, Prognosis, and Management of New Clinically Important Atrial Fibrillation After Noncardiac Surgery: A Prospective Cohort Study. Issue 5 (October 2017)

• Record Type: Journal Article
• Authors: Alonso-Coello, P.; Cook, D.; Xu, S. C.; Sigamani, A.; Berwanger, O.; Sivakumaran, S.; Yang, H.; Xavier, D.; Martinez, L. X.; Ibarra, P.; Rao-Melacini, P.; Pogue, J.; Zarnke, K.; Paniagua, P.; Ostrander, J.; Yusuf, D.; Devereaux, P. J.
• Is Part Of: Survey of anesthesiology. Volume 61:Issue 5/6(2017)
• Publication Date: 2017-10
• Subjects: Anesthesiology -- Periodicals; 617.96
• DOI: 10.1097/01.sa.0000527545.40789.1d
• Languages: English
• ISSNs: 0039-6206

Abstract

Abstract : (Abstracted from Anesth Analg, 125(1):162–169, 2017) The purpose of the POISE (PeriOperative ISchemic Evaluation) trial substudy has multiple objectives: it aims to deduce the associations between new clinically important atrial fibrillation (AF) and patient outcomes, as well as patient management strategies, while identifying a valid clinical prediction model for new clinically important AF in patients undergoing noncardiac surgery.